doi:10.1016/j.bmcl.2007.02.028
Copyright © 2007 Elsevier Ltd All rights reserved.
Synthesis of soluble multivalent glycoconjugates that target the Hc region of botulinum neurotoxin A
Ramesh R. Kalea, Colin M. Clancyb, Rebecca M. Vermilliona, Eric A. Johnsonb and Suri S. Iyera,
, 
a301 Clifton Court, Department of Chemistry, University of Cincinnati, Cincinnati, OH 45221, USA
b1925 Willow Drive, Department of Food Microbiology and Toxicology, Food Research Institute, University of Wisconsin–Madison, Madison, WI 53706, USA
Received 26 December 2006;
revised 6 February 2007;
accepted 9 February 2007.
Available online 14 February 2007.
References and further reading may be available for this article. To view references and further reading you must
purchase this article.
Abstract
The design, synthesis, and initial inhibitory studies of di- and tetravalent glycoconjugates that target the heavy chain of botulinum neurotoxin A are reported.
Graphical abstract
The design, synthesis, and initial inhibitory studies of di- and tetravalent glycoconjugates that target the heavy chain of botulinum neurotoxin A are reported.
Keywords: Glycoconjugates; Multivalent; Botulinum A
Figure 1. Structures of GT1b (left) and designer divalent ligand (right).
Figure 2. Structures of homodimers (A and C), mixed heterodimer (B), and tetramers (D and E).
Scheme 1. Reagents and conditions: (a) chloroacetyl chloride, 4 M NaOH 82%; (b) aq NH3, 12 h, rt, 91%; (c) CBzCl, NaHCO3, rt, 12 h, 79%; (d) propargyl amine, CDMT, NMM, THF/DMF, 0 °C → rt, 32 h, 81%.
Scheme 2. Reagents and conditions: (a) NaOH, di-tert-butyl-dicarbonate, DMF/H2O, rt, 30 h, 67%; (b) propargyl amine, CDMT, NMM, THF/DMF, 0 °C → rt, 32 h, 85%; (c) TFA, triisopropylsilane, rt, 8 h, 80%; (d) bromoacetyl bromide, Na2CO3, CH3CN, rt, 96%; (e) NH3 in MeOH, rt, 81%; (f) 4, CDMT, NMM, THF/DMF, 0 °C→ rt, 32 h, 78%.
Scheme 3. Reagents and condition: (a) NH2NH2·AcOH, THF, 85%; (b) Cl3CCN, K2CO3, DCM, 82%; (c) H(OCH2CH2)3N3, TMSOTf, DCM, 0 °C, 74%.
Scheme 4. Reagents: (a) Et2NH, DMF, 92%.
Scheme 5. Reagents: (a) CuSO4, sodium ascorbate, THF/H2O, 57%; (b) 14, CuSO4, sodium ascorbate, THF/H2O, 71%; (c) NaOMe, MeOH ; (d) aq NaOH, 86% (over two steps).
Figure 3. Western blot analysis depicting the inhibitory capacity of the ligands. Lanes A, B, C, D, and E represent compounds A, B, C, D, and E of Figure 2, respectively. Lane F represents the mixture of ligands. Lane G contains no sample. Lanes H, I, and J are controls; H has anti-toxin, I represents only toxin, and J has no toxin (Please see text for details) MM is the molecular marker.